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Abstract 
Many in-vitro methods for prediction of skin permeability have been reported in literature. 
Cerasome electrokinetic chromatography is one of the most sophisticated approaches representing a 
maximum level of similarity to the lipid phase of the stratum corneum. One goal of this study was to 
investigate the affinity pattern of Cerasome and to compare it with the permeability profile of human 
skin. Another purpose was to study the applicability of Hansen solubility parameters for modelling 
skin permeation and to investigate the predictive and explanatory potential of this method. 
Visualisation in Hansen diagrams revealed very similar profiles of Cerasome electrokinetic 
chromatography retention factors and skin permeability coefficients. In both cases, the characteristic 
pattern with two clusters of highly retained or highly permeable substances could be shown to be 
mainly caused by two groups of compounds, one of them with high affinity to ceramides, fatty acids 
and lecithin and the other being more affine to cholesterol. If based on a sufficiently comprehensive 
experimental dataset, model-independent predictions of skin permeability data using three-
component Hansen solubility parameters are able to achieve similar accuracy as calculations made 
with an Abraham linear free energy relationship model in which the compounds are characterized by 
seven physicochemical descriptors. 
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Introduction 
The transdermal administration route is one of oldest, safest, and most convenient for the patient 
and can be used for both, local and systemic therapy. However, the primary function of the skin is 
that of a barrier rather than of an absorption organ. An important role is played by the stratum 
corneum, the outermost layer of the epidermis. It consists of 15-25 layers of non-viable cells, each of 
which is about 0.2-0.5 mm thick. As they had become cornified in their terminal stage of 
differentiation, they are mainly composed of keratin. The interstices between these corneocytes are 
tightly sealed with various lipids, accounting for about 5-15% of the stratum corneum [1]. Though the 
stratum corneum is the thinnest layer of the skin at the preferred application sites it is the rate 
limiting structure for transepidermal drug transport. Disregarding the less pronounced drug 
penetration via pores (transglandular, transfollicular), two types of transepidermal transport can be 
distinguished: the transcellular and the intercellular route [2]. In case of the first mentioned type the 
drug has to pass both, the intercellular lipid layers and the hydrophilic cytoplasma and keratin 
structures, which requires a very well balanced hydrophilicity/lipophilicity ratio of the molecules [3]. 
Hence, for many drugs and other substances permeation through the skin is mainly accomplished by 
intercellular transport where the drug diffuses through the lipid filled interstices between the 
corneocytes [4].  
 
The steady-state flux, Js,v of a drug from a vehicle through the skin can be derived, according to Fick’s 
laws, from the concentration of the drug in the vehicle (cv) and the permeability coefficient, kp [5]: 
 
vpvs ckJ ,  (1) 
 
kp is defined as the product of the partition coefficient (Ps,v) and the diffusion coefficient (Ds) divided 
by the thickness of the skin (hs).  
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Thus Js,v depends on the partition of the drug between the vehicle and the skin. In case of 
intercellular transport this means partition between the vehicle and the intercellular lipids. It is 
known that Ds correlates only slightly with the chemical structure of the substance, however Ps,v is 
strongly related to the structural properties of the molecules. Hence, the permeability coefficient of 
lipid soluble substances is essentially determined by the lipid/water distribution, which is 
consequently a main factor governing the flux through the skin. The determination of solubilities in 
stratum corneum lipids poses experimental difficulties e.g. with respect to a standardized and well 
defined composition of the mixture. For this reason the solubility in other lipophilic solvents, most 
commonly octanol, is used as a surrogate [6]. However, in contrast to stratum corneum lipids, those 
substances, like aliphatic alcohols or hydrocarbons, are uncharged and do not show similar 
interactions with electrolytes as they have to be assumed, for example, with stratum corneum fatty 
acids. In addition, the ordered structure of lipids arranged in membranes might account for a 
modified affinity to different solutes as compared with a physical mixture of the same lipids. 
 
For this reason, many in-vitro models, mimicking the composition and the structure of human 
stratum corneum, have been investigated so far in order to mathematically describe the process of 
skin permeation. Likewise, different methods have been studied to analyse the raw data obtained in 
such experimental setups. Many of these methods aim to predict the skin penetration from chemical, 
physicochemical or structural data of the compounds without subjecting them to any experimental 
test. One of these methods is linear free energy relationship analysis (LFER). The study presented 
here investigates another approach. Based on data obtained from electrokinetic chromatography 
(LEKC) and human skin permeation, Hansen solubility parameters (HSP) were applied for data 
analysis, and advantages and disadvantages of this method were studied in comparison to LFER.  
As mentioned above, partitioning of the drug into the stratum corneum lipids is only one crucial step 
in drug skin permeation. Another step is the diffusion through the intercellular space. With in-vitro 
skin models it is not possible to analyze these processes individually. Quantitative structure-property 
relationship approaches modelling the drug skin permeation process as a whole do not facilitate a 
differentiated analysis of individual factors of influence. For this reason LEKC was applied as a model 
to obtain data reflecting exclusively partitioning into stratum corneum lipids. By separate analysis of 
both steps, partitioning and diffusion, much deeper insight can be gained regarding the significance 
and role of involved structures and molecules. 
 
Theory  
Liposome electrokinetic chromatography (LEKC) 
Chromatographic methods based on immobilized artificial membranes (IAMs, monolayers of 
phospholipid analogs covalently bonded to the surface of silica particles) and micelles (BMC = 
biopartitioning micellar chromatography) have been applied to better mimic the lipid structures in 
the stratum corneum and to improve the prediction of lipid distribution and skin penetration [7,8]. 
One of the most sophisticated techniques in this field is liposome electrokinetic chromatography 
(LEKC) [9,10]. As liposomes possess lipid bilayer structures they resemble biological biomembranes 
much more than the aforementioned systems. Most studies applying LEKC for studying skin 
penetration have used conventional phosphatidylcholine (PC)/ phosphatidylserine (PS) liposomes 
which do not reflect the composition of the lipid layers in the stratum corneum. Zhang et al. 
performed LEKC measurements using Cerasome 9005, a 6.6% (w/w) vesicular dispersion composed 
of hydrogenated lecithin, ceramides (NP and NS), cholesterol and fatty acids (palmitic acid and oleic 
acid) [11]. The mixture resembles the composition of the stratum corneum lipids which consist of 40-
50% ceramides, about 25% sterols, mainly cholesterol, and 10-20% free fatty acids. However, in 
contrast to Cerasome, the intercellular stratum corneum lipids are free of phospholipids. Anyway, 
they form multilamellar sheets as a result of the steric interaction of amphiphilic ceramides with 
cholesterol and free fatty acids [12-15]. Originally developed and marketed as a prefabricated 
liposome dispersion for cosmetic and drug formulation, the Cerasome dispersion was used by the 
cited authors as a running solution in LEKC, in order to model drug partitioning in stratum corneum 
lipids and consequently skin permeation. With these data, collected from 71 different compounds, 
they established a quantitative relationship between the structurally determined physicochemical 
descriptors and the retention factors in LEKC using LFER. 
 
Linear free energy relationship analysis (LFER) 
LFER in a broader sense is a type of a quantitative structure-property relationship (QSPR). It 
represents a mathematical model able to predict physicochemical properties (e.g. permeation, 
absorption, partitioning, solubility or, in case of this work, LEKC retention factors) from chemical 
molecular descriptors of a substance. In LFER the logarithm of the physicochemical property depends 
linearly on a free energy change as also the various descriptors are related to Gibbs free energy. A 
widely used model, developed by Abraham is based on the following equation, 
 
  JjJjvVbBaAsSeEcSPlog  (3) 
 
where SP is a free energy-related physicochemical property of a compound in a given solvent system. 
The lower case letters (e, s, a, b, v, j+, j-) are system constants describing the contribution of the 
solvent phase to the sorption process [11]. The capital letters are solute descriptors representing the 
properties of the compounds. In detail, these are the excess molar refraction (E), the solute 
dipolarity/polarizability (S), the overall solute hydrogen bond acidity (A) and hydrogen bond basicity 
(B), the McGowan characteristic volume (V), a descriptor for cations (J+), and another for anions (J-). 
V is calculated by summing up all atom volumes of the molecule and subtracting 6.56 cm3 mol-1 for 
each bond. Zhang et al. demonstrated that Eq. (3) is able to describe both the retention factors in 
LEKC and the distribution coefficient at pH 7.4 (D7.4) between water and different solvents for all 
tested compounds including non-ionic and ionic substances [11].  
 
Solubility parameters 
Another, quite different approach for computation of solubility related properties is the application 
of solubility parameters. A main purpose of this study is the comparison of both systems, LFER and 
solubility parameters, with respect to their ability to predict and interpret skin penetration behaviour 
and the properties of different substances in in-vitro models. In order to work out and to understand 
analogies and differences between both systems, some general considerations on solubility 
parameters have to be made first.  
 
The concept of solubility parameters is based on the cohesive energy density (CED) which is the 
energy per unit volume necessary to separate the molecules of a solute or solvent to a distance 
where all cohesive interactions have disappeared. The simplest system of solubility parameters () 
was introduced by Hildebrand and Scott, who defined them as the square root of the CED: 
 
  5.0mv VECED   (4) 
 
where Ev is the energy of vaporization and Vm is the molar volume [16]. According to Eq. (5), 
materials having similar solubility parameters have a low non-combinatorial free energy of mixing, 
GMnoncomb, and therefore a high affinity for each other. 
 
 22121   M
M
noncomb VG  (5) 
 
1 and 2 are the volume fractions of the components and VM is the volume of the mixture. The non-
combinatorial free energy of mixing includes all free energy effects other than the combinatorial 
entropy of solution, occurring because of simple mixing the components [17]. As the free energy of 
mixing (GM) is the difference between the non-combinatorial energy change and the combinatorial 
entropy change (TSMcomb),   
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the maximum difference of solubility parameters which is just small enough for solution to occur (i.e. 
GM = 0), can be calculated from the condition 
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It follows from the above that GMnoncomb includes both terms by which G
M of a real solution differs 
from that of an ideal solution, the excess enthalpy and the excess entropy. When calculating the 
mole fraction solubility, X2, of a substance in a solvent forming a real solution these corrections are 
accounted for by the rational activity coefficient, 2.  
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where X2
i is the ideal mole fraction solubility, Hf is the heat of fusion of the solute, T is the 
temperature and T0 is the melting point of the solute, V2 is the molar volume of the solute, 1 is the 
volume fraction of the solvent and R is the gas constant. w11 and w22 are the energy required to 
generate a void between adjacent solvent molecules and the energy required to overcome the 
attractive forces between the solute molecules, respectively. The square roots of these energies 
represent the Hildebrand solubility parameters of the solvent (1) and the solute (2). Inserting these 
parameters, Eq. (8) can be written as 
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Though still widely used, the concept of Hildebrand takes insufficient account of the fact that 
different types of forces are acting between the molecules in a mixture, all of them contributing to 
the miscibility and other interaction properties. Many approaches have been made to introduce 
corrections or to subdivide the Hildebrand parameters into partial solubility parameters dedicated to 
different types of intermolecular interactions. The most widely used method is a three-component 
parameter model proposed by C.M. Hansen [17]. He introduced a system of three parameters, d, p, 
and h, contributing to dispersive (van der Waals), polar and hydrogen-bond interactions, 
respectively.  
 
hpdt    (10) 
 t is the total solubility parameter which is numerically equal to the Hildebrand parameter. Using 
only three components, Hansen solubility parameters (HSPs) have the advantage to be visualizable in 
a three-dimensional coordinate system. Another benefit is that HSPs for a huge number of various 
substances are listed in literature and that group contribution methods allow for estimation of HSP 
values on the basis of a given structure formula.  
 
Due to its high versatility, the HSP concept has gained widespread use, in many fields of application, 
like solvent selection, polymer synthesis and engineering, surface characterization, chemical and 
biological compatibility studies, and even in pharmaceutical development, e.g. in the areas of drug 
formulation [18-28] or permeability across biological barriers [30,31]. Also the use of solubility 
parameters (Hansen or Hildebrand) for prediction of skin transport was investigated [5, 32-35].  
 
As the first summand in Eq. (9) is the ideal mole fraction solubility X2
i, the logarithm of the rational 
activity coefficient ln 2 can be written as  
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Consequently the squared difference of the solubility parameters can be expressed as 
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In terms of Hansen parameters, the simple univariate quadratic polynomial of Eq. (12) can be 
extended to a trivariate polynomial, 
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which can also be written as [36] 
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with D0, D1, D2, D3and D’0, D’1, D’2, D’3 being constants. 
 As is evident from Eq. (13) and Eq. (14), also the solubility parameter approach can be considered as 
a linear combination of terms attributed to different types of intermolecular interactions, similar to 
the Abraham LFER model. However, in this case the descriptors (1x-2x) do not represent the solute 
properties as such but the differences between solvent and solute properties. Whilst in the Abraham 
LFER approach the solvent specific constants include both, the solvent properties and a scaling factor 
to fit the predicted quantity, the constants D and D’ in Eq. (13) and Eq. (14) are mere scaling factors, 
correlating each pair (squared difference) of solvent and solute parameter to the physicochemical 
target property (ln X2). As the solubility parameter approach separates the scaling factors from the 
solvent parameters, it may better allow for comparing the response for different solvents. As the 
description of the predicted property is not centred to a particular solvent, it facilitates the graphical 
depiction of the relationships between solvents and solutes in a diagram with an absolute origin 
which is not determined by the applied solvent. 
 
Irrespective of these advantages, the classical Hansen model has one major drawback. The systems 
of Hildebrand and Hansen solubility parameters are based on the “similarity matching” rule “like 
dissolves like”. However, it should be considered that particularly in case of acidic and basic 
components (or also in case of Lewis acids and bases) “complementary matching” can be the 
dominating principle. In order to quantify electron-donor and -acceptor properties, Beerbower et al. 
developed a four parameter system in which h is substituted by an acidic (a) and a basic (b) 
solubility parameter (h
2  =2ab) [37]. This subdivision of the hydrogen-bonding parameter into an 
acidity and a basicity component has its analogue in the overall solute hydrogen bond acidity and 
basicity descriptors in LFER. Unfortunately, in contrast to HSBs, only very limited sources of a and b 
values are available in literature and a group contribution methods does not exist. For this reason, 
this study was based on three-component Hansen parameters in their non-expanded form. 
 
A main goal of this work was to study the applicability of the HSP method to analyze the behaviour of 
different compounds in Cerasome LEKC. It is scrutinized whether the Hansen approach is able to 
elucidate further relationships remaining latent with the Abraham model and whether it can thus 
support or complement the Abraham approach. Furthermore, the applicability of HSPs to predict the 
distribution of compounds in other model systems and the permeation through human skin are 
addressed. 
 
Materials and methods 
All following considerations regarding the interpretation of LEKC retention factors are based on a 
comprehensive dataset created by Zhang, K. et al. [11], which comprises experimentally determined 
log k7.4 values of 70 compounds (Tab. 1, see Appendix). For comparison with skin penetration data, 
another set of 168 substances was compiled from 6 different sources (Tab. 2, see Appendix). Hansen 
solubility parameters were taken from literature if available. In all other cases, where experimentally 
determined values could not be found, HSPs were calculated using the group contribution method of 
Hoftyzer and van Krevelen [38]. Octanol-water distribution coefficients (log D7.4) were compiled from 
six sources. If not available from literature they were calculated either with ACD/PhysChem Suite 
(ACD/Labs) or with the Property viewer of ChemAxon chemicalize.org, both accessible via the 
chemical database ChemSpider (Royal Society of Chemistry, London, UK) (www.chemspider.com). 
 
Results and discussion 
All calculations and considerations made in this study are based on the two sets of data mentioned in 
the materials and methods section. One of them comprises in-vitro data measured with Cerasome 
LEKC, the other encompasses human skin penetration data compiled from different sources of 
literature. To every compound of each dataset a three-component HSP was assigned, describing its 
interaction properties with respect to dispersive, polar, and hydrogen bonding forces. If available 
from literature, experimentally determined HSP values were used. In all other cases HSPs were 
calculated by a group contribution method. HSPs are always subject to a certain level of uncertainty, 
which is lower in case of experimentally created data. HSPs obtained by group contribution are 
described to have an accuracy of approximately 10% [39]. Visualization of LEKC retention factors or 
stratum corneum permeabilities in dependence of HSPs requires plotting a dependent variable 
versus three independent variables (d, p, h). As these four-dimensional datasets cannot be 
visualized in plane diagrams, different methods have been developed in the past to solve this 
problem by means of data reduction. One approach is to merge two partial solubility parameters by 
pythagorian addition, for example d and p, as realized in Bagley diagrams [33]. Another approach, 
known as Teas plot, is the presentation of fractional solubility parameters (e.g. d d + p + h)) in a 
three component diagram. All these methods have in common a loss of information thus distorting 
the results [40]. For this reason, three dimensional diagrams (often called Hansen space) were 
chosen here to depict the retention or permeation properties of the tested substances in correlation 
to HSPs. 
 
Fig.1 
 
Description of Cerasome LEKC retention factors in terms of HSPs 
Fig. 1 shows the data points of all compounds tested in LEKC experiments within the Hansen space. 
The retention factors are represented by different shapes of the markers. In contrast to Hansen’s 
basic concept, where all good solvents are clustered within one single solubility sphere, no such 
single-centered area covering the data points of all compounds with large retention factors can be 
found in this diagram. Instead not only one but two focal areas are formed by strongly retained 
substances which are separated by a broad region with data points of better eluting compounds. One 
of these clusters can be found in the region of d = 15 to 18 MPa
1/2, p = 0 to 4 MPa
1/2 and a second 
cluster is seen between d = 19 to 21 MPa
1/2, p = 3 to 8 MPa
1/2. Such a pattern of more than one area 
of high solubility is described to be typical for surfactants and copolymers [41, 42]. It is characteristic 
for molecules in which sites with different interactive properties are spatially separated from one 
another or where such sites of a number of molecules cluster together. By contrast, mixtures of 
different types of small molecules without any ordered supramolecular structure do not show multi-
centered pattern of solubility in HSP diagrams. Instead, they reveal a single solubility maximum 
whose coordinates can be calculated as the volume-fraction-weighted average of the components’ 
HSPs. Hence, the complex pattern of LEKC retention factors within the Hansen space indicates 
interactions either with amphiphilic molecules or with ordered structures. Looking at the 
components of Cerasome 9005, this product represents a mixture of a variety of amphiphilic 
compounds. In view of its liposomal nature it must be assumed that most of the components are 
regularly arranged, thus forming extended hydrophilic and hydrophobic regions. It is difficult to 
derive experimentally determined HSP values for lecithin, ceramides, cholesterol and fatty acids from 
literature. Only for the last two mentioned substances tabular values could be found. HSPs for 
dipalmitoylphosphatidylcholine (DPPC) and N-stearoyl sphingosine (as typical members of the 
lecithin- and ceramide group) were calculated using the method of Hoftyzer and van Krevelen [38]. 
Fig. 2 shows the HSP coordinate positions of the Cerasome components together with the test 
samples of the LEKC experiments. Interestingly, compounds with high k7.4 values are mainly clustered 
around the data points of the Cerasome lipids, indicating mutual interactions. The solubility 
parameters of lecithin, ceramides and fatty acids are relatively close to each other with d being in 
the range of 16.3 to 16.8 MPa1/2, p ranging from 1.3 to 2.8 MPa
1/2, and h between 5.6 and 8.5 
MPa1/2. As can be seen by comparison with hexadecane (d = 16.3 MPa
1/2, p = 0 MPa
1/2, h = 0 
MPa1/2) and octadecane (d = 16.4 MPa
1/2, p = 0 MPa
1/2, h = 0 MPa
1/2), d is mainly determined by 
the aliphatic chains of the lipids. From homologue series of hydrocarbons it can be deduced that 
longer chains result in higher d values. However, values of 20 MPa
1/2 and above cannot be explained 
by aliphatic carbon chains. As solubility parameters represent the cohesion energy per molar volume, 
such high dispersion parameters are characteristic for compactly structured polycyclic hydrocarbons 
like cholestane. For this reason, d of cholesterol (20.4 MPa
1/2) [43] is incomparably higher than the 
value of the other lipids. Due to the amphiphilic character of cholesterol, enabling hydrogen bonding 
as well as van der Waals binding to low polar compounds,  it can be assumed that p and h 
parameters of substances with affinity to cholesterol are ranging over a wide scale. Indeed, the 
cluster of strongly retained compounds around the data point of cholesterol shows a large extension 
both in p and h direction. In summary, strongly retained compounds form two clusters in the 
Hansen space, one caused by the affinity to cholesterol and the other by binding to lecithin, 
ceramides and fatty acids. Both clusters are divided from each other by a region comprising the data 
points of substances with low k7.4 values. As discussed before, the occurrence of two separate 
solubility regions, which is typically not observed with mixtures of miscible substances, raises the 
suspicion that in the Cerasome liposomes cholesterol is not molecularly dispersed within the other 
lipids but in some way separated. Indeed, it is reported that ternary mixtures of 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine, ceramide (18:0) and cholesterol with fractions of 50% ceramide and 
25% cholesterol, resembling the ratio in stratum corneum lipids, reveal a separate phase of 
cholesterol monohydrate crystals besides a bilayer phase containing all three components [44]. Also 
in lipid membranes separated sphingolipid and cholesterol-rich ordered lipid domains are believed to 
exist [45]. 
 
Fig.2 
 
As was shown in a former work of the author, the contours of such irregularly shaped solubility 
regions are determined by the plurality of different molecular fragments of a large molecule or a 
supramolecular structure [40]. By contrast, small molecular compounds and also their mixtures are 
characterized by a single centred solubility sphere. In this case, according to Hansen, the solubility of 
a substance in another can be estimated from the relative energy difference (RED). The RED is 
calculated from the Euclidean distance in the three-dimensional Hansen space between the data 
point of one substance and the center of the other substance’s solubility sphere and is defined as the 
ratio of this distance and the sphere’s interaction radius R.  
 
       RRED chphcpppcdpd
5.0222
4    (15) 
 
A RED lower than 1 indicates high solubility (coordinate position within the sphere), a RED higher 
than 1 characterizes substances with low solubility (coordinate position outside the sphere). 
However, in case of Cerasome the complex-shaped and even divided solubility region makes the 
classical Hansen approach inapplicable. 
 
As it is nearly impossible to describe such irregular shapes by a single formula, it likewise renders 
difficult to find a simple mathematical correlation which is able to predict the solubility, or in this 
case the LEKC retention factor, from HSPs. For this reason, it is more expedient to use the use the full 
data set of known log k7.4 values for prediction instead of reducing it to an approximation formula 
with loss of valuable information. However, because of the irregular shape of the solubility region in 
the Hansen space there is no predictable influence of more distant data points, so that only a local 
approximation is reasonable. The necessary basis for this method is a training set of a sufficient 
number of homogenously scattered data points without major gaps in between. The simplest way of 
prediction is by using a k-nearest neighbour algorithm, assigning the value of an object to the 
average value of its k nearest neighbors. As the dataset in Tab. 1 unfortunately exhibits poorly 
covered regions with large distances to the closest data points, the k-nearest neighbor method can 
only be applied in a limited way, i.e. excluding the prediction of points which are too far from any 
point of the training set. In order to test the method without separate sets of training and sample 
data being available, log k7.4 of each compound in the list was predicted by using the data of all other 
compounds except the respective one as a trainings set. With k = 2 it could be shown that the 
method works with high accuracy for all data for which the distance to the nearest point of the 
trainings set is smaller than 1 MPa1/2 (average deviation of log k7.4: 0.20) (Fig. 3). However, as can be 
seen by some outliers, in rare cases, where a data point has to be extrapolated in a region with 
steeply increasing response values, mispredictions cannot entirely be prevented. Nevertheless, if a 
sufficiently large, dense and equally distributed training dataset is available it can be expected that 
this model-independent method allows highly accurate predictions. As HSPs can be easily calculated 
by simple group contribution methods, the presented approach allows the prediction of interactions 
of any organic substances with stratum corneum lipids directly from the molecular structure without 
the need of sophisticated computer programs. Surprisingly, Fig. 3 shows that neutral, anionic and 
cationic compounds are fitted equally well by the same regression line. Hence, this example does not 
identify any necessity to consider charged compounds in a special way. 
 
Fig.3 
 
LFER analysis as described by Zhang et al., however, considers the charge state of the tested 
compounds [11]. By regressing Eq. (3) on the dataset of Tab. 1, they developed the following formula 
for k7.4: 
 
  JJVBSk 912.1164.0782.1427.1587.0844.1log 4.7  (16) 
 
Fig. 4. shows the values predicted by this linear relationship equation for the same compounds as in 
Fig. 3. Comparison of both diagrams reveals very similar results of both methods (R2HSP = 0.86, R
2
LFER = 
0.90; Slope of the linear trendline: HSP: 0.84, LFER: 0.90). However it should not be overlooked that 
the HSP method needs a much larger training dataset (or a better interpolation algorithm) in order to 
predict the whole range of sample compounds with sufficient accuracy. 
 
Fig.4 
 
Description of octanol-water distribution coefficients in terms of HSPs  
Another more commonly used in-vitro-parameter which was also often applied for the prediction of 
skin permeability is the octanol-water partition coefficient P or, if all dissociation species at pH 7.4 
are considered, the octanol-water distribution coefficient D7.4. However, compared to log kp, a 
different picture emerges if log D7.4 is displayed in the Hansen diagram (Fig. 5). Data points 
representing high log D7.4 values form a widespread cloud. The HSP of octanol does not form the 
center of this cluster, as one might expect from Hansen theory. It has to be considered that, as log 
D7.4 does not describe the solubility in octanol but the distribution between octanol and water, this 
parameter is also a function of the compounds’ aqueous solubility.  
 
The center of the solubility sphere of water is reported as d = 15.1 MPa
1/2, p = 20.4 MPa
1/2, h = 16.5 
MPa1/2 and the sphere’s interaction radius is given as 18.1 MPa1/2 (based on the assumption of 
“good” solutes being soluble to more than 1% in water) [46]. If the relative energy difference RED of 
the neutral components is plotted against the octanol-water partition coefficient, a RED value of 1 
can be correlated with a log D7.4 of about 2 (data not shown), which means that compounds with 
HSPs located outside the 1%-water-solubility sphere are distributed less than 1% within the water- 
and more than 99% within the octanol-phase. The same is also valid if the RED of acidic and basic 
compounds is plotted against log P, indicating that the neutral species of acids and bases partition in 
the same manner as non-dissociating compounds. Thus, it can be stated that log D7.4 and log P are 
substantially governed by the aqueous solubility of the compounds. This is in agreement to the 
known fact that for similar classes of compounds, excellent linear relationships exist between 
aqueous solubility cw and log P, as described by 
 
b
c
aP
w







1
loglog  (17) 
 
with a and b being constants [47, 48].  
 Fig.5 
 
It follows that the octanol-water distribution coefficient is not well suited as a model for partitioning 
of drugs into stratum corneum lipids. 
 
Description of human skin permeability coefficients in terms of HSPs 
Though Cerasome was developed to largely mimic the lipid composition in the stratum corneum, 
conditions in real skin are somewhat different from those in liposome dispersions. The differences do 
not only concern the structural arrangement of the lipid layers but also their composition. As 
mentioned in section 1.1.1, Cerasome contains lecithin which is not a component of the stratum 
corneum lipids. Nevertheless, compared to other in-vitro test systems for skin permeation, the 
Cerasome dispersion exhibits one of the closest analogies to human skin. Using a database with 
human skin permeability coefficients (kp) of 168 different compounds, the correlation with LEKC 
retention factors was analyzed. The permeability coefficients were compiled from different literature 
sources and averaged (Tab. 2). Fig. 6 shows the HSPs of the analyzed compounds as a graphical 
representation in the Hansen space with the permeability coefficients classified as different markers.  
 
Fig.6 
 
Compared to the LEKC data set, the compounds chosen for skin permeability analysis are spread over 
a more extended HSP range particularly towards lower d and higher p values. However, the 
distribution pattern of kp is largely the same as that of k7.4 in case of LEKC data. Again, there is one 
cluster of high kp values in the region of ceramides and fatty acids and another around the HSP of 
cholesterol. Also in this case, the k-nearest neighbor method, as described in section 3.1, is able to 
predict the kp values from the HSPs of the compounds. Fig. 7 shows the correlation between 
predicted and measured kp values. As done before with k7.4 values, each value of the data set in Tab. 
2 was predicted on the basis of all other data, which were used as the training set. The predicted 
value was assigned to the average value of the three nearest neighbor points. Because of the large 
size of the data set on which the method is based, the number of predictable data points did not 
have to be restricted. The average deviation of log kp was 0.51. Hence, this example demonstrates 
the performance of the method. The accuracy might be increased by the application of a more 
sophisticated interpolation algorithm, like the modified Shepards method described by Renka, R.J. 
[49, 50, 40]. 
 
Fig.7 
 
This data analyses demonstrate that LEKC retention factors as well as human skin permeability 
coefficients are predictable from Hansen solubility parameters. They show that compounds which 
are highly retained in LEKC and those which are well permeable through human skin have similar 
HSPs and thus comparable distribution patterns in the Hansen space. This congruence is somewhat 
surprising as it is known, that skin permeability is not only governed by the water/stratum corneum 
partitioning but also by diffusion within the stratum corneum. Hence, kp depends on both the water 
skin partition coefficient ksc and the diffusion coefficient in the stratum corneum Dsc, as described by 
the following equation,  
 
h
D
kk scscp logloglog   (18) 
 
in which h is the thickness of the stratum corneum [51]. As k7.4 quantifies a partitioning process into a 
lipid system similarly composed as the stratum corneum it is supposed to be a good estimate for ksc 
[51]. Dsc was reported to be a function of the molecular volume Vm,  
 
 mscsc VbDD  exp
0  (19) 
 
with D0sc being the diffusivity of a molecule with a vanishing small Vm and b a constant which is 
inversely proportional to the average free volume available for diffusion [6]. From Eq. (19) a 
proportionality between log Dsc and -Vm can be deduced. It may therefore be concluded that log kp 
should be linearly related not only to log k7.4 but also to -Vm. However, as follows from the very 
similar distribution pattern of LEKC retention and skin permeation in the Hansen space, the latter 
seems to be mainly governed by stratum corneum lipid partitioning and, for a wide range of 
substances, to be determined only to a minor degree by diffusion properties. 
 
Conclusion 
Summarizing these data, the distribution of substances into Cerasome liposomes is primarily 
governed by specific affinities to the four main components of this system with the different 
solubility behaviour of cholesterol playing a special role. By contrast, the octanol-water distribution 
was found to be largely determined by a more unspecific displacement of hydrophobic compounds 
from the aqueous phase. The affinity of different compounds to Cerasome can be portrayed using 
Hansen solubility parameters. As Cerasome resembles the stratum corneum lipids not only with 
respect to their composition but also concerning their lamellar arrangement, it constitutes an 
excellent in-vitro test system for skin partition. The high similarity to stratum corneum lipids is also 
expressed in a largely similar pattern of k7.4 and kp intensity distributions in the Hansen space. In both 
systems a main reason for the complex relationship between skin permeability or LEKC retention on 
the one hand and the different kinds of interactive forces on the other are the different solubility 
effects of cholesterol and the other lipids.  
 
Appendix 
Data tables 
 
Table 1. LEKC retention factors (log k7.4), octanol-water partition and distribution coefficients at pH 
7.4 (log P and log D7.4), LFER solute descriptors, and Hansen solubility parameters d, p, h) of 70 
substances tested with Cerasome electrokinetic chromatography [11] (Zhang et al., 2011).  One 
substance of the original dataset was omitted, because the HSP of iodinated compounds can not be 
calculated by current group contribution methods. 
Compound d 
MPa1/
2 
p 
MPa1/2 
h 
MPa1/2 
Charge 
state 
log 
Poct 
log 
D7.4 
log 
k7.4 
E S A B V J
+
 J
-
 
Cortexolone 18.8 4.6 12.5 neutral 2.52 2.52 -1.11 1.91 3.45 0.36 1.60 2.738
9 
0 0 
Cortexone 18.4 4.2 9.2 neutral 2.88 2.88 -0.82 1.74 3.50 0.14 1.31 2.680
2 
0 0 
Corticosterone 18.6 4.6 12.4 neutral 1.94 1.94 -1.27 1.86 3.43 0.40 1.63 2.738
9 
0 0 
Cortisone 19.1 5.4 12.8 neutral 1.47 1.47 -1.57 1.96 3.50 0.36 1.87 2.754
6 
0 0 
Dexamethasone 18.6 4.7 14.7 neutral 1.83 1.83 -1.40 2.04 3.51 0.71 1.92 2.913
2 
0 0 
Digitoxin 18.7 3.0 14.6 neutral 1.86 1.86 -1.12 3.46 5.56 1.67 4.35 5.693
8 
0 0 
Estriol 18.7 3.8 16.2 neutral 2.54 2.54 -1.37 1.97 1.74 1.06 1.63 2.257
5 
0 0 
Hydrocortisone 19.0 4.9 15.1 neutral 1.55 1.55 -1.47 2.03 3.49 0.71 1.90 2.797
6 
0 0 
Hydrocortisone-21-acetate 18.6 4.3 12.6 neutral 2.19 2.19 -1.41 1.89 2.88 0.46 2.16 3.095
1 
0 0 
17-Hydroxyprogesterone 18.4 4.2 9.2 neutral 3.17 3.17 -0.90 1.64 3.35 0.25 1.31 2.680
2 
0 0 
Prednisolone 19.0 5.1 15.3 neutral 1.62 1.62 -1.50 2.21 3.10 0.71 1.92 2.754
6 
0 0 
Testosterone 18.3 3.6 9.3 neutral 3.29 3.29 -0.85 1.54 2.59 0.32 1.19 2.382
7 
0 0 
Bibenzyl 18.6 0.6 0.0 neutral 4.80 4.80 0.72 1.22 1.04 0.00 0.33 1.606
0 
0 0 
4-Chloro-2-methylphenol 20.3 6.5 13.3 neutral 2.78 2.78 -0.74 0.89 0.91 0.63 0.22 1. 38
4 
0 0 
4-Chloro-3,5-dimethylphenol 20.9 5.7 12.4 neutral 3.27 3.27 -0.51 0.93 0.96 0.64 0.21 1.179
3 
0 0 
3,4-Dimethylphenol 17.0 4.2 12.9 neutral 2.23 2.23 -1.34 0.83 0.90 0.55 0.38 1.056
9 
0 0 
1-Fluoro-2,4-dinitrobenzene 21.2 12.9 5.1 neutral 1.47 1.47 -1.63 1.01 1.69 0.00 0.45 1.082
5 
0 0 
2-Naphthol 19.7 6.3 12.3 neutral 2.70 2.70 -0.70 1.52 1.08 0.61 0.40 1.144
1 
0 0 
Resorcinol 18.0 8.4 21.0 neutral 0.80 0.79 -1.49 0.98 1.11 1.09 0.52 0.833
8 
0 0 
Styrene 17.6 0.6 0.0 neutral 2.95 2.95 -0.62 0.85 0.65 0.00 0.16 0.955
2 
0 0 
Toluene 17.5 1.0 0.0 neutral 2.73 2.73 -0.83 0.60 0.52 0.00 0.14 0.857
3 
0 0 
4-BrC6H4OH 21.3 4.9 13.9 neutral 2.59 2.58 -0.87 1.08 1.17 0.67 0.20 0.950
1 
0 0 
3-CH3C6H4OH 18.0 5.1 12.9 neutral 1.96 1.96 -1.48 0.82 0.88 0.57 0.34 0.916
0 
0 0 
4-CH3C6H4OH 18.3 4.9 13.9 neutral 1.95 1.95 -1.43 0.82 0.87 0.57 0.31 0.916
0 
0 0 
C6H5COCH3 19.6 8.6 3.7 neutral 1.58 1.58 -1.64 0.82 1.01 0.00 0.48 1. 13
9 
0 0 
2-ClC6H4NH2 19.3 5.4 9.2 neutral 1.91 1.91 -1.50 1.03 0.92 0.25 0.31 0. 39
0 
0 0 
2-ClC6H4NO2 19.6 10.7 4.1 neutral 2.52 2.52 -1.27 1.02 1.24 0.00 0.24 1. 13
0 
0 0 
3-ClC6H4OH 19.3 7.5 14.3 neutral 2.50 2.49 -1.05 0.91 1.06 0.69 0.15 0.897
5 
0 0 
Compound d 
MPa1/
2 
p 
MPa1/2 
h 
MPa1/2 
Charge 
state 
log 
Poct 
log 
D7.4 
log 
k7.4 
E S A B V J
+
 J
-
 
4-ClC6H4OH 19.3 7.5 14.3 neutral 2.39 2.39 -1.01 0.92 1.08 0.67 0.20 0.897
5 
0 0 
4-ClC6H4CH2OH 18.7 6.4 13.2 neutral 1.96 1.96 -1.36 0.91 0.96 0.40 0.50 1.038
4 
0 0 
2-H2NC6H4Ph 19.0 1.0 7.3 neutral 2.84 2.84 -1.06 1.60 1.48 0.26 0.41 1. 24
0 
0 0 
3-O2NC6H4OH 19.9 11.9 14.7 neutral 2.00 1.96 -0.83 1.05 1.57 0.79 0.23 0.949
3 
0 0 
PhCH2CN 19.5 12.3 3.8 neutral 1.56 1.56 -1.61 0.75 1.03 0.00 0.50 1.012
0 
0 0 
PhCH2OH 18.4 6.3 13.7 neutral 1.10 1.10 -1.66 0.80 0.87 0.39 0.56 0.916
0 
0 0 
PhNH2 18.6 1.2 9.6 neutral 0.90 0.90 -1.73 0.96 0.96 0.26 0.41 0.816
2 
0 0 
PhNHEt 18.2 1.9 5.0 neutral 2.16 2.16 -1.52 0.95 0.85 0.17 0.43 1.098
0 
0 0 
PhNO2 20.0 8.6 4.1 neutral 1.85 1.85 -1.49 0.87 1.11 0.00 0.28 0.890
6 
0 0 
PhOH 18.0 5.9 14.9 neutral 1.47 1.47 -1.56 0.81 0.89 0.60 0.30 0.775
1 
0 0 
Acridine 19.6 5.4 5.8 neutral 3.40 3.39 -0.51 2.36 1.32 0.00 0.58 1.413
3 
0 0 
Aspirin 18.7 4.7 11.0 anion 1.13 -2.79 -2.20 0.93 3.91 0.04 3.03 1.266
4 
0 2.122
7 Flurbiprofen 19.4 2.2 7.0 anion 3.81 0.32 -1.21 1.59 4.56 0.07 3.36 1.817
4 
0 2.538
3 Ibuprofen 16.4 7.7 7.2 anion 3.87 0.90 -1.19 0.88 3.50 0.08 3.31 1.755
6 
0 2.418
8 Ketoprofen 19.5 5.5 7.8 anion 2.77 -0.34 -1.32 1.80 5.49 0.01 3.39 1.956
4 
0 2.485
1 Mefenamic acid 20.3 2.5 8.1 anion 5.12 2.05 -1.17 1.80 4.71 0.09 3.14 1.899
6 
0 2.642
7 Naproxen 18.1 6.2 9.2 anion 3.06 -0.19 -1.43 1.66 5.07 0.02 3.11 1.760
6 
0 2.426
0 4-BrC6H4COOH 19.9 3.7 9.2 anion 2.86 -0.57 -1.16 1.15 3.47 0.04 2.61 1.085
2 
0 2.250
4 1-C10H7COOH 20.5 3.2 8.6 anion 3.10 -0.61 -1.61 1.61 4.13 0.05 2.87 1. 79
2 
0 2. 04
1 3-ClC6H4COOH 18.9 5.9 9.3 anion 2.71 -0.86 -1.58 0.99 3.25 0.04 2.68 1.032
6 
0 2.201
0 4-ClC6H4COOH 19.0 5.9 9.4 anion 2.65 -0.77 -1.39 0.99 3.31 0.04 2.60 1.032
6 
0 2.187
3 C6H5COOH 19.2 4.3 9.9 anion 1.96 -1.24 -1.16 0.88 3.05 0.02 2.75 0.910
2 
0 2.138
5 C6H5(CH2)2COOH 18.8 3.3 8.7 anion 1.89 -1.26 -1.37 0.90 3.43 0.03 3.02 1.192
0 
0 2.187
9 C6H5(CH2)3COOH 18.5 2.9 8.2 anion 2.42 -0.26 -1.67 0.91 3.59 0.04 3.01 1.332
9 
0 2.218
4 C6H5(CH2)4COOH 18.3 2.6 7.8 anion 2.85 0.00 -1.63 0.92 3.63 0.04 3.10 1.471
8 
0 2.279
4 C6H5(CH2)7COOH 17.8 2.0 6.8 anion 4.09 1.72 -1.31 0.94 3.87 0.07 3.26 1. 96
5 
0 2. 25
6 4-MeC6H4CH2NHMe 17.2 1.6 4.6 cation 1.96 -0.57 -0.63 0.63 2.64 1.47 0.00 1.260
4 
1.262
2 
0 
4-MeC6H4CH2NHEt 17.2 1.4 4.4 cation 2.38 -0.26 -0.63 0.61 2.69 1.48 0.00 1. 01
3 
1. 64
7 
0 
4-MeC6H4CH2NHPr 17.1 1.3 4.1 cation 2.96 0.38 -0.56 0.59 2.68 1.45 0.00 1.542
2 
1.260
5 
0 
4-MeC6H4CH2NHBu 17.0 1.2 4.0 cation 3.49 0.91 -0.44 0.57 2.68 1.46 0.00 1.683
1 
1.240
5 
0 
4-MeC6H4CH2NH(CH2)4Me 17.0 1.1 3.8 cation 4.26 1.58 -0.08 0.55 2.66 1.41 0.00 1.824
0 
1.252
2 
0 
4-MeC6H4CH2NH(CH2)5Me 16.9 1.0 3.7 cation 4.96 2.19 0.26 0.54 2.45 1.29 0.00 1.964
9 
1. 26
8 
0 
4-MeC6H4CH2NH(CH2)6Me 16.9 1.0 3.5 cation 5.12 2.50 0.95 0.53 2.51 1.47 0.00 2.105
8 
1.121
5 
0 
Acebutolol 18.0 4.3 10.5 cation 2.02 -0.10 -1.01 1.45 6.69 3.62 0.00 2.777
1 
2.296
5 
0 
Alprenolol 17.1 4.3 9.9 cation 3.10 0.91 0.06 1.10 4.46 1.78 0.00 2. 80
2 
2.257
4 
0 
Metoprolol 17.7 7.0 10.1 cation 1.95 -0.28 -0.79 1.02 5.35 2.16 0.00 2. 81
9 
2.347
6 
0 
Oxprenolol 17.1 4.8 10.8 cation 2.51 0.34 -0.50 1.16 5.09 2.35 0.00 2.238
9 
2.202
9 
0 
Penbutolol 17.3 2.4 9.6 cation 4.62 2.10 0.74 0.78 4.66 1.98 0.00 2.619
5 
1. 63
0 
0 
Pindolol 18.7 3.3 11.6 cation 1.75 -0.39 -0.83 1.55 4.60 2.36 0.00 2.030
5 
2.266
1 
0 
Propafenone 17.9 3.3 9.5 cation 3.64 1.42 0.45 1.55 5.67 2.97 0.00 2.846
7 
2.346
7 
0 
Propranolol 19.2 7.9 10.0 cation 3.48 1.35 0.47 1.69 4.31 2.07 0.00 2.169
5 
2.431
9 
0 
Timolol 17.3 6.2 13.1 cation 1.83 0.01 -0.82 1.32 5.67 2.83 0.00 2.397
4 
2.269
2 
0 
 
 
Table 2. Skin permeability coefficients (log kp), octanol-water distribution coefficients at pH 7.4 (log 
D7.4) and Hansen solubility parameters d, p, h) of 168 substances. Compounds which are 
undissociated to an extend of more than 80% at pH 7.4 are referred to as neutral. Those which are 
undissociated less than 20% at pH 7.4 are referred to as anions or cations. All other compounds are 
partially dissociated (20-80% undissociated) and labelled with “a/n” (anionic/neutral) or “c/n” 
(cationic/neutral). 
Compound d p h Ref. log kp 
(cm/h) 
Ref. Charge 
state 
log 
D7.4 
Ref. 
1,1,1-Trichloroethane 17.7 9.9 3.5 j -2.34 a,b neutral 2.49 b,c 
1,3-Dichloropropene 16.6 8.2 2.9 j -2.00 a neutral 1.82 o 
17-Hydroxyprogesterone 18.4 4.2 9.2 j -3.22 d,e,a neutral 2.74 d,e 
2,3-Butanediol 15.7 7.8 21.0 j -4.17 d,e,a,f,p neutral -0.92 d,e,c,f 
2,4,6-Trichlorophenol 19.6 8.7 13.1 j -1.23 d,e,a,f,b anion 2.70 o 
2,4-Dichlorophenol 21.3 8.3 13.6 j -1.22 d,e,a,f,b neutral 3.10 d,e,c,f,b 
2-Butoxyethanol 15.8 4.9 13.2 j -2.85 a neutral 0.80 i 
2-Chlorophenol 20.3 5.5 13.9 k -1.36 d,e,a,f,b,p neutral 2.16 d,e,c,f,b 
2-Cresol 18.2 4.9 13.9 j -1.68 d,e,a,f,b,p neutral 1.97 d,e,c,f,b 
2-Ethoxyethanol 16.1 9.2 14.3 k -3.48 d,e,a,f,b,p neutral -0.47 d,e,c,f,b 
2-Heptanone 16.2 5.7 4.1 k -2.00 a neutral 1.97 i 
2-Hexanone 15.3 6.1 4.1 k -2.35 a neutral 1.44 i 
2-Hydroxypropyl nicotinate 16.2 8.5 14.1 j -3.99 p neutral 0.27 i 
2-Methoxyethanol 16.2 9.2 16.4 k -3.73 a neutral -0.80 i 
2-Naphthol 19.7 6.3 12.3 j -1.47 d,e,a,f,b,p neutral 2.78 d,e,c,f,b 
2-Pentanone 15.4 7.1 4.3 j -2.60 a neutral 0.91 i 
2-Phenylethanol 18.2 4.3 12.9 j -1.71 a,b,f,p neutral 1.50 o 
2-Toluidine 19.4 5.8 9.4 k -1.44 a neutral 1.40 i 
3,4-Xylenol 17.0 4.2 12.9 j -1.32 d,e,a,f,b,p neutral 2.23 q 
3-Cresol 18.0 5.1 12.9 k -1.70 d,e,a,f,b,p neutral 1.96 q 
3-Nitrophenol 19.9 11.9 14.7 j -2.25 d,e,a,f,b neutral 1.96 q 
3-Xylene 17.3 0.9 0.0 j -1.10 a neutral 3.14 i 
4-Bromophenol 21.3 4.9 13.9 j -1.32 d,e,a,f,b,p neutral 2.59 d,e,c,f,b 
4-Chloro-3,5-xylenol 20.9 4.0 12.4 j -1.13 d,e,a,f,b,p neutral 3.39 d,e,c,f,b 
4-Chloro-m-cresol 20.3 6.5 13.3 j -0.78 p neutral 2.88 i 
4-Chloro-m-phenylenediamine 19.0 5.2 12.7 j -2.98 p neutral 0.84 i,o 
4-Chloro-o-cresol 20.3 6.5 13.3 j -1.25 d,e,a,f,b neutral 3.10 d,e,c,f,b 
4-Chlorophenol 19.3 7.5 14.3 j -1.32 d,e,a,f,b,p neutral 2.39 d,e,c,f,b 
4-Cresol 18.3 4.9 13.9 j -1.63 d,e,a,f,b,p neutral 1.94 d,e,c,f,b 
4-Ethylphenol 18.0 4.2 12.9 j -1.34 d,e,a,f,b,p neutral 2.46 d,e,c,f,b 
4-(Hydroxymethyl)phenol 19.3 7.0 19.8 j -2.70 p neutral 0.40 i 
4-Hydroxy-methylphenylacetate 20.5 5.0 15.1 j -1.70 p neutral -1.77 i 
4-Hydroxyphenylacetamide 19.9 5.8 17.1 j -3.33 p neutral 0.18 i 
4-MeC6H4CH2NH(CH2)4Me 17.0 1.1 3.8 j -2.44 p cation 1.58 q 
4-MeC6H4CH2NH(CH2)5Me 16.9 1.0 3.7 j -2.31 p cation 2.19 q 
4-MeC6H4CH2NH(CH2)6Me 16.9 1.0 3.5 j -2.14 p cation 2.50 q 
4-MeC6H4CH2NHBu 17.0 1.2 4.0 j -3.16 p cation 0.91 q 
4-MeC6H4CH2NHEt 17.2 1.4 4.4 j -3.41 p cation -0.26 q 
4-MeC6H4CH2NHMe 17.2 1.6 4.6 j -4.15 p cation -0.57 q 
4-MeC6H4CH2NHPr 17.1 1.3 4.1 j -3.41 p cation 0.38 q 
4-Methyl-2-pentanol 15.1 4.0 12.6 j -2.33 a neutral 1.57 i 
4-Nitrophenol 19.9 11.9 14.7 j -2.25 d,e,a,f,b a/n 1.94 d,e,c,f,b 
5,5-Diethylbarbituric acid 
(Barbital) 
16.7 8.5 8.7 j -3.90 d,e,a,f,b,p a/n 0.69 i,o 
5-Ethyl-5-(3-methylbutyl) 
barbituric acid (Amobarbital) 
16.4 6.5 7.6 j -2.59 d,e,a,f,b,p a/n 2.06 i,o 
5-Ethyl-5-butylbarbituric acid 
(Butobarbital) 
16.6 7.0 7.9 j -3.65 d,e,a,f,p a/n 1.71 i,o 
5-Ethyl-5-phenylbarbituric acid 
(Phenobarbital) 
18.2 4.3 6.7 j -3.29 d,e,a,f,b,p a/n -3.11 i,o 
5-Fluorouracil 19.6 13.3 11.0 j -3.26 p a/n -1.64 i 
Compound d p h Ref. log kp 
(cm/h) 
Ref. Charge 
state 
log 
D7.4 
Ref. 
8-Methoxypsoralen 21.9 6.6 8.3 j -1.56 p neutral 1.52 i 
Acetic acid 14.5 8.0 13.5 k -3.21 a anion -2.90 o 
Acrylic acid 16.7 6.2 12.1 j -3.05 a anion -2.90 o 
Acrylonitrile 16.0 12.8 6.8 k -2.87 a neutral 0.19 i 
Aldosterone 19.0 5.4 13.1 j -4.69 d,e,a,f,b,p neutral 1.08 d,e,c,f,b 
Allyl alcohol 15.3 7.1 16.8 j -2.95 a neutral 0.17 i 
Aniline 18.6 1.2 9.6 j -1.83 a,b,p neutral 0.91 b 
Anisole 17.2 3.7 5.1 j -1.25 a,f,b,p neutral 2.11 c,f,b 
Benzaldehyde 18.8 8.0 6.7 j -0.91 a,f,b,p neutral 1.48 c,f,b 
Benzene 15.5 0.0 0.0 j -0.86 a,f,b,p neutral 2.12 c,f,b 
Benzyl alcohol 18.4 6.3 13.7 k -1.88 d,e,a,f,b,p neutral 1.10 d,e,c,f,b,q 
Benzyl nicotinate 18.3 3.0 7.5 j -1.31 p neutral 2.48 i 
Butanoic acid 16.7 4.7 10.6 j -3.00 d,e,a anion -1.91 o 
Butanone 15.3 8.4 4.7 j -2.18 d,e,a,f,p neutral 0.29 d,e,c,f 
Butyl acrylate 15.6 3.4 7.0 j -2.00 a neutral 2.39 i 
Butyl nicotinate 16.7 3.1 7.7 j -1.30 p neutral 2.32 i 
C6H5(CH2)2COOH 18.8 3.3 8.7 j -1.57 p neutral -1.26 q 
C6H5(CH2)3COOH 18.5 2.9 8.2 j -1.49 p neutral -0.26 q 
C6H5(CH2)4COOH 18.3 2.6 7.8 j -0.94 p neutral 0.00 q 
C6H5(CH2)7COOH 17.8 2.0 6.8 j -0.50 p neutral 1.72 q 
C6H5COOH 19.2 4.3 9.9 j -1.55 p anion -1.24 q 
Caffeine 20.8 13.3 12.9 j -3.87 a,f,p neutral -0.05 c,f 
Catechol 20.0 11.3 21.8 k -2.77 a neutral 0.88 i 
Chlorpheniramine 17.3 5.1 6.5 j -2.66 d,e,a,b cation 1.04 o 
Cortexolone 18.8 4.6 12.5 j -4.13 d,e,a,b neutral 2.52 d,e,b 
Cortexone 18.4 4.2 9.2 j -3.35 d,e,a,b neutral 2.88 d,e,b 
Corticosterone 18.6 4.6 12.4 j -3.75 d,e,a,f,b,p neutral 1.94 d,e,c,f,b 
Cyclohexanone 15.9 7.5 4.4 j -2.74 a neutral 0.76 i 
Dexamethasone 18.6 4.7 14.7 j -4.03 a,f,p neutral 1.91 c,f 
Diclofenac 21.3 4.5 8.2 j -2.31 a,f,b anion 1.44 o 
Diethyl ether 14.7 2.8 5.5 j -2.05 d,e,a,f,b,p neutral 0.83 d,e,f,b 
Diethylamine 14.9 1.4 5.5 j -2.75 a cation -2.25 o 
Diethylcarbamazine 16.4 8.1 9.3 j -3.46 d,e,a,b,p c/n 0.08 o 
Digitoxin 18.7 3.0 14.6 j -4.79 d,e,a,b,p neutral 2.44 i 
Dimethyl acetamide 16.8 11.5 10.2 k -2.80 a neutral 0.21 o 
Dimethyl formamide 17.4 13.7 11.3 k -1.98 a neutral -0.83 o 
Dimethyl sulfoxide 18.4 16.4 10.2 k -1.80 a neutral -1.35 i 
Ephedrine 17.2 3.4 11.9 j -2.22 d,e,a,f,b cation -0.93 o 
Estradiol 18.4 3.0 13.1 j -2.45 d,e,a,f,b,p neutral 2.91 d,e,f,b 
Estriol 18.7 3.8 16.2 j -4.40 d,e,a,b neutral 2.47 d,e,b 
Estrone 19.6 4.0 9.7 j -2.44 d,e,a,b neutral 2.76 d,e,b 
Ethanol 15.8 8.8 19.4 k -2.96 d,e,a,f,b,p neutral -0.31 d,e,c,f,b 
Ethyl acrylate 15.5 7.1 5.5 k -2.39 a neutral 1.32 i 
Ethyl benzene 17.3 0.9 0.0 j  0.62 d,e,a,f,p neutral 3.15 d,e,c,f 
Ethyl formate 13.2 10.6 7.8 j -3.01 a neutral 0.30 i 
Ethyl nicotinate 16.8 3.9 8.6 j -1.72 p neutral 1.30 i 
Ethylene dichloride 17.1 6.5 3.1 j -2.00 a neutral 1.41 i 
Ethylene glycol 17.0 11.0 26.0 k -4.07 a neutral -1.69 i 
Etorphine 19.8 3.5 9.9 j -2.44 d,e,a,b cation 1.92 o 
Fentanyl 18.7 4.5 6.2 j -2.26 d,e,a,f,b cation 2.61 o 
Fluocinonide 18.1 4.3 9.8 j -2.77 d,e,a,f,b,p neutral 3.19 d,e,c,f,b 
Formaldehyde 10.7 18.3 10.1 j -2.65 a neutral 0.35 o 
Glycerol trinitrate 17.8 14.6 10.0 j -1.65 p neutral 2.15 i 
Compound d p h Ref. log kp 
(cm/h) 
Ref. Charge 
state 
log 
D7.4 
Ref. 
Heptanoic acid 16.6 3.0 8.5 j -1.70 d,e,a anion -0.36 o 
Hexachloroethane 19.7 7.3 4.3 j -1.40 a neutral 4.47 i 
Hexanoic acid 16.6 3.4 9.0 j -1.85 d,e,a anion -0.87 o 
Hexyl nicotinate 16.6 2.6 7.1 j -1.27 p neutral 3.34 i 
Hydrocortisone 19.0 4.9 15.1 j,l -4.43 d,e,a,f,b,p neutral 1.56 d,e,c,f,b 
Hydrocortisone 21-(6-
hydroxy)hexanoate 
18.1 3.6 11.6 j -2.92 d,e,a,f,b,p neutral 2.79 d,e,c,f,b 
Hydrocortisone 21-(N,N-
dimethyl)succinamate 
18.1 4.4 9.9 j -4.17 d,e,a,f,b,p neutral 2.03 d,e,c,f,b 
Hydrocortisone 21-hemipimelate 18.3 3.5 10.2 j -2.73 d,e,a,f,b,p anion 0.25 o 
Hydrocortisone 21-
hemisuccinate 
18.5 3.9 10.9 j -3.18 d,e,a,f,b,p anion -0.47 o 
Hydrocortisone 21-hexanoate 17.8 3.4 9.0 j -1.74 d,e,a,f,b,p neutral 4.04 d,e,c,f,b 
Hydrocortisone 21-
methylpimelate 
15.9 3.3 9.5 j -2.27 d,e,a,f,b,p neutral 3.50 d,e,c,f,b 
Hydrocortisone 21-
methylsuccinate 
18.0 3.7 10.1 j -3.68 d,e,a,f,b,p neutral 3.58 d,e,c,f,b 
Hydrocortisone 21-octanoate 17.7 3.1 8.6 j -1.21 d,e,a,f,b,p neutral 5.49 d,e,c,f,b 
Hydrocortisone 21-pimelamate 18.1 3.8 10.2 j -2.93 d,e,a,f,b,p neutral 2.31 d,e,c,f,b 
Hydrocortisone 21-propionate 17.9 3.9 9.6 j -2.47 d,e,a,f,b,p neutral 3.00 d,e,c,f,b 
Hydrocortisone 21-succinamate 18.3 4.3 10.8 j -4.59 d,e,a,f,b,p neutral 1.43 d,e,c,f,b 
Hydroxypregnenolone 18.4 3.6 12.1 j -3.22 d,e,a,b neutral 3.00 d,e,b 
Indometacin 19.9 5.1 8.7 j -2.44 a,f,b anion 0.98 o 
Isoamyl alcohol 15.3 4.6 13.5 j -2.00 a neutral 1.22 i 
Isobutanol 15.1 5.7 15.9 k -2.65 a neutral 0.68 o 
Isoquinoline 18.9 6.6 6.5 j -1.72 d,e,a,f,b,p neutral 2.07 d,e,c,f,b 
Lidocaine 18.5 5.0 6.7 j -2.09 a,f,b c/n 1.67 o 
Mannitol 18.6 10.7 32.4 j -4.86 p neutral -3.26 i 
Meperidine 16.9 4.0 7.2 j -2.43 d,e,a,b cation 1.62 o 
Methacrylic acid 16.9 5.0 10.9 j -2.58 a anion -2.20 o 
Methanol 15.1 12.3 22.3 k -3.14 d,e,a,f,b,p neutral -0.74 d,e 
Methyl 4-hydroxybenzoate 18.2 5.6 14.7 j -1.92 d,e,a,f,b,p neutral 1.96 d,e,c,f,b 
Methyl acrylate 15.3 6.7 9.4 k -2.68 a neutral 0.79 i 
Methyl nicotinate 16.8 4.4 9.2 j -2.21 p neutral 0.88 i 
Methylene chloride 17.8 6.4 6.1 k -2.74 a neutral 1.53 i 
Methyltriglycol nicotinate 16.6 3.7 8.9 j -3.27 p neutral   
Monomethylhydrazine 16.2 8.7 14.8 k -3.75 a cation -2.82 o 
N,N-Dimethylaniline 18.0 6.3 6.3 j -1.70 a neutral 2.33 i 
Naproxen 18.1 6.2 9.2 j,l,m -2.84 d,e,a,f,b anion 0.35 o 
n-Butanol 16.0 5.7 15.8 k -2.52 d,e,a,f,b,p neutral 0.88 d,e,c,f,b 
n-Decanol 16.0 2.6 10.2 j -0.93 d,e,a,f,b,p neutral 4.20 d,e,c,f 
n-Heptanol 15.9 3.5 11.9 j -1.41 d,e,a,f,b,p neutral 2.62 d,e,c,f,b 
n-Hexanol 15.8 4.0 12.6 j -1.71 d,e,a,f,b,p neutral 2.03 d,e,c,f,b 
Nicotine 20.5 6.6 10.7 j -1.72 d,e,a,f,b cation -0.62 o 
Nitroglycerine 16.2 17.8 5.9 k -1.96 d,e,a,b neutral 1.87 d,e,c,b 
n-Methyl-2-pyrrolidone 18.0 11.5 8.5 j -1.80 a neutral -0.40 i 
n-Nonanol 16.0 2.9 10.7 j -1.10 d,e,a,f,b,p neutral 3.80 d,e,f,b 
n-Octanol 15.9 3.2 11.2 j -1.11 d,e,a,f,b,p neutral 3.07 d,e,c,f,b 
n-Pentanol 15.7 4.6 13.6 j -2.10 d,e,a,f,b,p neutral 1.51 d,e,c,f,b 
n-Propanol 16.0 6.8 17.4 k -2.77 d,e,a,f,b,p neutral 0.28 d,e,c,f,b 
Octanoic acid 15.1 3.3 8.2 k -1.60 a anion 0.15 o 
o-Phenylenediamine 19.5 0.8 13.4 j -3.14 p neutral 0.05 i 
Ouabain 18.9 4.2 21.2 j -6.11 a,b,p neutral -2.85 c,b 
Pentanoic acid 16.7 4.0 9.7 j -2.70 a anion -1.39 o 
Compound d p h Ref. log kp 
(cm/h) 
Ref. Charge 
state 
log 
D7.4 
Ref. 
Phenol 18.0 5.9 14.9 k -1.93 d,e,a,f,b,p neutral 1.46 d,e,c,f,b 
Phenylglycidyl ether 18.2 4.3 6.7 j -2.84 a neutral 1.74 i 
Piroxicamc 18.9 7.1 13.6 j -2.46 p neutral 1.68 i 
p-Phenylenediamine 19.5 0.8 13.4 j -3.42 p neutral -0.71 i 
Pregnenolone 18.0 3.2 8.7 j -2.82 d,e,a neutral 3.13 d,e,b 
Progesterone 18.0 3.8 3.7 j -2.08 d,e,a,f,b,p neutral 3.84 d,e,c,f,b 
Propionic acid 14.7 5.3 12.4 k -2.94 a anion -2.39 o 
Propylene oxide 15.2 8.6 6.7 k -3.05 a neutral 0.13 i 
Resorcinol 18.0 8.4 21.0 k -3.50 d,e,a,f,b,p neutral 0.80 d,e,c,f,b 
Salicylic acid 19.4 10.1 17.4 k -2.32 d,e,a,f,b anion -1.14 o 
Scopolamine 19.2 4.9 12.3 j -4.30 d,e,a,f,b c/n 0.05 o 
Styrene 17.6 0.6 0.0 j -0.19 d,e,a,f neutral 2.95 d,e,c,f 
Sucrose 17.7 7.5 27.8 j -5.28 d,e,a,b neutral -2.74 d,e,c,b 
Testosterone 18.3 3.6 9.3 j -2.74 d,e,a,f,b,p neutral 3.31 d,e,c,f,b 
Thymol 16.5 3.2 11.4 j -1.15 d,e,a,f,p neutral 3.33 d,e,c,f,b 
Toluene 17.5 1.0 0.0 j -0.04 d,e,a,p neutral 2.74 d,e,c 
Triglycol nicotinate 16.4 5.6 13.3 j -4.52 p neutral   
Urea 20.9 18.7 26.4 k -4.37 p neutral -1.66 i 
Vinyl acetate 16.0 7.2 5.9 k -2.73 a neutral 0.73 i 
 
a) Reference [52] (Santos-Filho et al., 2004), b) Reference [53] (Wilschut et al., 1995), c) Reference [54] (Hansch 
and Leo, 1979), d) Reference [55] (Flynn, 1990), e) Reference [56] (Barratt, 1995), f) Reference [57] (Johnson et 
al., 1997), g) Reference [58] (Pugh et al., 2000), h) Reference [59] (Hansch et al., 1995), i) Calculated with the 
software ACD/ChemSketch Freeware (version 10.00, Advanced Chemistry Development, Inc., Toronto, ON, 
Canada, www.acdlabs.com, 2006), j) Calculated by the group contribution method accordingt to Hoftyzer, Van 
Krevelen [38] (van Krevelen, 1990), k) Reference [17] (Hansen, 2007a), l) Reference [60] (Dwan`Isa, 2005), m) 
Reference [61] (Bustamante et al., 1998), n) Reference [62] (Peña et al., 2000), o) ChemSpider (Royal Society of 
Chemistry, London, UK) (www.chemspider.com), p) Reference [51]Zhang et al., 2012), q) Reference [11] (Zhang 
et al., 2011)  
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Figure captions 
 
Fig. 1: LEKC retention factors of the compounds tested for retention in Cerasome LEKC: Data 
locations of 70 tested substances in the Hansen space (perspective view and d/p-view). Solid 
squares (with drop lines): log k7.4 > 0, solid triangles (with drop lines): log k7.4: 0 to -0.75, open 
squares: log k7.4 < -0.75.  
 
Fig. 2: LEKC retention factors of the compounds tested for retention in Cerasome LEKC: Data 
locations of 70 tested substances in the Hansen space (perspective view and d/p-view). Solid 
squares (with drop lines): log k7.4 > 0, solid triangles (with droplines): log k7.4: 0 to -0.75, open 
squares: log k7.4 < -0.75, open circles: components of Cerasome 9005.  
 
Fig. 3: LEKC retention factors (log k7.4) predicted from HSPs (nearest neighbourhood method) vs. 
measured log k7.4-values (Compounds with HSP data points more distant than 1 MPa
1/2 to the nearest 
point of the model’s trainings set were excluded from prediction for lack of accuracy). Squares: acids, 
diamonds: neutral compounds, triangles: bases. 
 
Fig. 4: LEKC retention factors (log k7.4) of the same subset of compounds as in Fig. 3 predicted with 
LFER. Squares: acids, diamonds: neutral compounds, triangles: bases. 
 
Fig. 5: Octanol-water distribution coefficients (log D7.4) of compounds tested for human stratum 
corneum penetration: Data locations of 168 tested substances in the Hansen space (perspective view 
and d/p-view). Solid squares (with anchor lines in the perspective view): log D7.4 > 2.5, solid 
triangles: log D7.4: 2.5 to 2, open squares: log D7.4 < 2, open circle: octanol. The perspective view 
shows also the solubility sphere of water. 
 
Fig. 6: Human skin permeability coefficients (log kp) of compounds tested for human stratum 
corneum penetration: Data locations of 141 tested substances in the Hansen space (perspective view 
and d/p-view). Solid squares (with drop lines): log kp > -1.2, solid triangles (with drop lines): log kp: -
1.2 to -1.32, open squares: log kp < -1.32, open circles: components of stratum corneum lipids and 
the lecithin component DPPC. 
 
Fig. 7: Human skin permeability coefficients (log kp) predicted from HSPs (nearest neighbourhood 
method) vs. measured log kp -values. Squares: acids, diamonds: neutral compounds, triangles: bases. 
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